Negative Regulation of miR-375 by Interleukin-10 Enhances Bone Marrow-Derived Progenitor Cell-Mediated Myocardial Repair and Function after Myocardial Infarction

Stem Cells

Volumn 33, Issue 12, 2015, Pages 3519-3529

  Garikipati, Venkata Naga Srikanth ^a   Krishnamurthy, Prasanna ^b   Verma, Suresh Kumar ^a   Khan, Mohsin ^a   Abramova, Tatiana ^c   Mackie, Alexander R ^c   Qin, Gangjian ^c   Benedict, Cynthia ^a   Nickoloff, Emily ^a   Johnson, Jennifer ^a   Gao, Ehre ^a   Losordo, Douglas W ^c   Houser, Steven R ^a   Koch, Walter J ^a   Kishore, Raj ^a,c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Angiogenesis; Bone marrow progenitor angiogenic cells; Inflammation; Left ventricular remodeling; miRNA

Indexed keywords

ANGIOPOIETIN 1; ASCORBIC ACID; CASPASE 3; CASPASE 7; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN GROWTH FACTOR 1; INTERLEUKIN 10; MICRORNA 375; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; RECOMBINANT INTERLEUKIN 10; SCATTER FACTOR; SOMATOMEDIN; SOMATOMEDIN C; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; IL10 PROTEIN, MOUSE; MICRORNA; MIRN375 MICRORNA, MOUSE;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW PROGENITOR CELL; CARDIOVASCULAR FUNCTION; CELL FUNCTION; CELL HYPOXIA; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; EX VIVO STUDY; GENE EXPRESSION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE ISCHEMIA; HEART PROTECTION; KNOCKOUT MOUSE; MALE; MOUSE; MYOCARDIAL REPAIR; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE REPAIR; UPREGULATION; ANIMAL; BONE MARROW CELL; CARDIAC MUSCLE; GENE SILENCING; GENETICS; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; BONE MARROW CELLS; GENE KNOCKDOWN TECHNIQUES; INTERLEUKIN-10; MICE; MICE, KNOCKOUT; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84983196513     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2121     Document Type: Article

References (30)

1. Assmus B, Schachinger V, Teupe C, et al., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
2. Losordo DW, Henry TD, Davidson C, et al., Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 2011; 109: 428-436.
3. Strauer BE, Brehm M, Zeus T, et al., Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918.
4. Losordo DW, Schatz RA, White CJ, et al., Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial. Circulation 2007; 115: 3165-3172.
5. Kandala J, Upadhyay GA, Pokushalov E, et al., Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. Am J Cardiol 2013; 112: 217-225.
6. Grisar J, Aletaha D, Steiner CW, et al., Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005; 111: 204-211.
7. Werner N, Nickenig G,. Influence of cardiovascular risk factors on endothelial progenitor cells: Limitations for therapy? Arterioscl Thromb Vasc Biol 2006; 26: 257-266.
8. Krishnamurthy P, Lambers E, Verma S, et al., Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J 2010; 24: 2484-2494.
9. Krishnamurthy P, Rajasingh J, Lambers E, et al., IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 2009; 104: e9-18.
10. Verma SK, Krishnamurthy P, Barefield D, et al., Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB. Circulation 2012; 126: 418-429.
11. Jones SP, Trocha SD, Lefer DJ,. Cardioprotective actions of endogenous IL-10 are independent of iNOS. Am J Physiol Heart Circ Physiol 2001; 281: H48-52.
12. Bartel DP,. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-233.
13. Krol J, Loedige I, Filipowicz W,. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610.
14. Almeida MI, Reis RM, Calin GA,. MicroRNA history: Discovery, recent applications, and next frontiers. Mutat Res 2011; 717: 1-8.
15. Krishnamurthy P, Thal M, Verma S, et al., Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res 2011; 109: 1280-1289.
16. Schaefer JS, Montufar-Solis D, Vigneswaran N, et al., Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol 2011; 187: 5834-5841.
17. Yan JW, Lin JS, He XX,. The emerging role of miR-375 in cancer. Int J Cancer 2014; 135: 1011-1018.
18. Keller DM, McWeeney S, Arsenlis A, et al., Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem 2007; 282: 32084-32092.
19. Baroukh NN, Van Obberghen E,. Function of microRNA-375 and microRNA-124a in pancreas and brain. FEBS J 2009; 276: 6509-6521.
20. Akat KM, Moore-McGriff D, Morozov P, et al., Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers. Proc Natl Acad Sci USA 2014; 111: 11151-11156.
21. Zhao H, Guan J, Lee HM, et al., Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition. Pancreas 2010; 39: 843-846.
22. Ito K, Akazawa H, Tamagawa M, et al., PDK1 coordinates survival pathways and beta-adrenergic response in the heart. Proc Natl Acad Sci USA 2009; 106: 8689-8694.
23. Mora A, Davies AM, Bertrand L, et al., Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J 2003; 22: 4666-4676.
24. Ling L, Shen Y, Wang K, et al., Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: Relevance to impaired endothelial progenitor cells mobilization. PLoS One 2012; 7: e50739.
25. Andreou I, Tousoulis D, Tentolouris C, et al., Potential role of endothelial progenitor cells in the pathophysiology of heart failure: Clinical implications and perspectives. Atherosclerosis 2006; 189: 247-254.
26. Liu Y, Wei J, Hu S, et al., Beneficial effects of statins on endothelial progenitor cells. Am J Med Sci 2012; 344: 220-226.
27. Budas GR, Sukhodub A, Alessi DR, et al., 3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium. FASEB J 2006; 20: 2556-2558.
28. Friedrich EB, Liu E, Sinha S, et al., Integrin-linked kinase regulates endothelial cell survival and vascular development. Mol Cell Biol 2004; 24: 8134-8144.
29. Papapetropoulos A, Fulton D, Mahboubi K, et al., Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 2000; 275: 9102-9105.
30. Izarra A, Moscoso I, Levent E, et al., miR-133a Enhances the protective capacity of cardiac progenitors cells after myocardial infarction. Stem Cell Rep 2014; 3: 1029-1042.